UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease

British journal of cancer, 2011-05, Vol.104 (11), p.1665-1669

2011

Volltextzugriff (PDF)

Primary thyroid lymphoma: The 40 year experience of a UK lymphoma treatment centre

International journal of oncology, 2012-06, Vol.40 (6), p.2075-2080

2012

Volltextzugriff (PDF)

The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid

European journal of cancer (1990), 2013-10, Vol.49 (15), p.3184-3190

2013

Volltextzugriff (PDF)

Adjuvant Interferon in High-Risk Melanoma: The AIM HIGH Study—United Kingdom Coordinating Committee on Cancer Research Randomized Study of Adjuvant Low-Dose Extended-Duration Interferon Alfa-2a in High-Risk Resected Malignant Melanoma

Journal of clinical oncology, 2004-01, Vol.22 (1), p.53-61

2004

Volltextzugriff (PDF)

Risk of Second Malignancy After Hodgkin’s Disease in a Collaborative British Cohort: The Relation to Age at Treatment

Journal of clinical oncology, 2000-02, Vol.18 (3), p.498-509

2000

Volltextzugriff (PDF)

Late spontaneous resolution of persistent molar pregnancy

BJOG : an international journal of obstetrics and gynaecology, 2016-06, Vol.123 (7), p.1175-1181

2016

Volltextzugriff (PDF)

Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors

British journal of cancer, 2013-06, Vol.108 (11), p.2399-2406

2013

Volltextzugriff (PDF)

Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial

The Lancet (British edition), 2003-08, Vol.362 (9383), p.516-522

2003

Volltextzugriff (PDF)

Follow-up care for cancer survivors: views of the younger adult

British journal of cancer, 2009-08, Vol.101 (4), p.561-567

2009

Volltextzugriff (PDF)

Follow-up care for cancer survivors: the views of clinicians

British journal of cancer, 2009-08, Vol.101 (4), p.568-574

2009

Volltextzugriff (PDF)

Primary bone lymphoma : A retrospective analysis

International journal of oncology, 2006-06, Vol.28 (6), p.1571-1575

2006

Volltextzugriff (PDF)

The skeletal metastatic complications of renal cell carcinoma

International journal of oncology, 2001-08, Vol.19 (2), p.379

2001

Volltextzugriff (PDF)

Prevalence and Consequences of Androgen Deficiency in Young Male Cancer Survivors in a Controlled Cross-Sectional Study

The journal of clinical endocrinology and metabolism, 2007-09, Vol.92 (9), p.3476-3482

2007

Volltextzugriff (PDF)

Quality of life and cost-effectiveness of interferon-alpha in malignant melanoma: results from randomised trial

British journal of cancer, 2006-02, Vol.94 (4), p.492-498

2006

Volltextzugriff (PDF)

Low-risk persistent gestational trophoblastic disease treated with low-dose methotrexate: efficacy, acute and long-term effects

British journal of cancer, 2003-12, Vol.89 (12), p.2197-2201

2003

Volltextzugriff (PDF)

Management and prognostic factors of epithelioid trophoblastic tumors: Results from the International Society for the Study of Trophoblastic Diseases database

Gynecologic oncology, 2019-02, Vol.152 (2), p.361-367

2019

Volltextzugriff (PDF)

Gestational trophoblastic disease in the Asian population of Northern England and North Wales

BJOG : an international journal of obstetrics and gynaecology, 2003-06, Vol.110 (6), p.555-559

2003

Volltextzugriff (PDF)

Adjuvant therapy of malignant melanoma

Critical reviews in oncology/hematology, 2002-10, Vol.44 (1), p.81-102

2002

Volltextzugriff (PDF)

Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519)

Annals of oncology, 2010-03, Vol.21 (3), p.568-573

2010

Volltextzugriff (PDF)

The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia

European journal of cancer (1990), 2019-03, Vol.109, p.162-171

2019

Volltextzugriff (PDF)

Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia

Gynecologic oncology, 2016-12, Vol.143 (3), p.565-570

2016

Volltextzugriff (PDF)

Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphoma

Annals of oncology, 2004-09, Vol.15 (9), p.1413-1418

2004

Volltextzugriff (PDF)

High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia

British journal of cancer, 2005-09, Vol.93 (6), p.620-621

2005

Volltextzugriff (PDF)

The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease

Gynecologic oncology, 2004-12, Vol.95 (3), p.423-429

2004

Volltextzugriff (PDF)

Second primary malignancies after treatment for malignant lymphoma

British journal of cancer, 2005-08, Vol.93 (4), p.418-424

2005

Volltextzugriff (PDF)

1 – 25 von 1.515

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.322)
Mit Volltextzugriff
(1.209)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease

Primary thyroid lymphoma: The 40 year experience of a UK lymphoma treatment centre

The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid

Adjuvant Interferon in High-Risk Melanoma: The AIM HIGH Study—United Kingdom Coordinating Committee on Cancer Research Randomized Study of Adjuvant Low-Dose Extended-Duration Interferon Alfa-2a in High-Risk Resected Malignant Melanoma

Risk of Second Malignancy After Hodgkin’s Disease in a Collaborative British Cohort: The Relation to Age at Treatment

Late spontaneous resolution of persistent molar pregnancy

Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors

Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial

Follow-up care for cancer survivors: views of the younger adult

Follow-up care for cancer survivors: the views of clinicians

Primary bone lymphoma : A retrospective analysis

The skeletal metastatic complications of renal cell carcinoma

Prevalence and Consequences of Androgen Deficiency in Young Male Cancer Survivors in a Controlled Cross-Sectional Study

Quality of life and cost-effectiveness of interferon-alpha in malignant melanoma: results from randomised trial

Low-risk persistent gestational trophoblastic disease treated with low-dose methotrexate: efficacy, acute and long-term effects

Management and prognostic factors of epithelioid trophoblastic tumors: Results from the International Society for the Study of Trophoblastic Diseases database

Gestational trophoblastic disease in the Asian population of Northern England and North Wales

Adjuvant therapy of malignant melanoma

Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519)

The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia

Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia

Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphoma

High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia

The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease

Second primary malignancies after treatment for malignant lymphoma

Suchergebnisse filtern